Page last updated: 2024-09-03

502u83 and Respiratory Insufficiency

502u83 has been researched along with Respiratory Insufficiency in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Clendeninn, NJ; Hohneker, JA; Janisch, L; Lucas, VS; Ratain, MJ; Ravitch, J; Schilsky, RL; Tuttle, RL; Vogelzang, NJ	1

Trials

1 trial(s) available for 502u83 and Respiratory Insufficiency

Article	Year
Phase I clinical and pharmacology study of 502U83 given as a 24-h continuous intravenous infusion. Cancer chemotherapy and pharmacology, 1993, Volume: 31, Issue:4 Topics: Adult; Aged; Anthracenes; Antineoplastic Agents; Chromatography, High Pressure Liquid; Clinical Trials, Phase I as Topic; Dose-Response Relationship, Drug; Electrocardiography; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Respiratory Insufficiency	1993

Article

Year

Phase I clinical and pharmacology study of 502U83 given as a 24-h continuous intravenous infusion.

Cancer chemotherapy and pharmacology, 1993, Volume: 31, Issue:4

Topics: Adult; Aged; Anthracenes; Antineoplastic Agents; Chromatography, High Pressure Liquid; Clinical Trials, Phase I as Topic; Dose-Response Relationship, Drug; Electrocardiography; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Respiratory Insufficiency

1993